Results 621-640 of 1,165,315 for in 'Dáil debates' OR in 'Committee meetings' (speaker:Ciarán Cuffe OR speaker:Michael McNamara OR speaker:Emer Higgins OR speaker:Mary Butler OR speaker:Paul Kehoe OR speaker:Michael Moynihan OR speaker:Maurice Quinlivan OR speaker:Marc MacSharry OR speaker:Ossian Smyth OR speaker:Michael Lowry OR speaker:Joe McHugh OR speaker:Claire Kerrane OR speaker:Holly Cairns OR speaker:Steven Matthews OR speaker:Neasa Hourigan OR speaker:Peadar Tóibín OR speaker:Thomas Byrne OR speaker:Colm Burke OR speaker:Peter Burke OR speaker:Cormac Devlin OR speaker:Anne Rabbitte OR speaker:Francis Noel Duffy OR speaker:Michael Creed OR speaker:Seán Fleming OR speaker:Matt Shanahan OR speaker:Brian Stanley OR speaker:Ivana Bacik OR speaker:Seán Haughey OR speaker:Michael McGrath OR speaker:Paschal Donohoe OR speaker:Alan Farrell OR speaker:James O'Connor OR speaker:Seán Ó Fearghaíl OR speaker:Brian Leddin OR speaker:Niamh Smyth OR speaker:Catherine Martin OR speaker:Duncan Smith OR speaker:Michael Collins)

Ceisteanna ar Sonraíodh Uain Dóibh - Priority Questions: Defence Forces (17 Oct 2024)

Matt Carthy: It is hard to ask a supplementary question when I do not have the substantive response to the question I asked. I take the Tánaiste's commitment to provide the precise figures. Here is what we do know from the Tánaiste's response. There are currently fewer than 7,500 members of our Defence Forces, 2,000 below the establishment figure and a whopping 4,000 below the two-figure...

Committee on Drugs Use: A Health-Led Approach: Discussion (Resumed) (17 Oct 2024)

Matt Shanahan: I thank the witnesses for attending. It is important to go back - the Cathaoirleach has signalled that this issue will probably be revisited - to try to understand what is the blockage to nurse prescribing. It happens in other areas of medicine, especially with the advanced clinical nurse practitioners. It is an obvious efficiency outcome and as the witnesses said, doctors may not be...

Committee on Drugs Use: A Health-Led Approach: Discussion (Resumed) (17 Oct 2024)

Matt Shanahan: Would any other speaker like to take that on as well?

Committee on Drugs Use: A Health-Led Approach: Discussion (Resumed) (17 Oct 2024)

Matt Shanahan: I want to ask both witnesses about monitoring. Dr. Kelly referenced a high level document he was not allowed to contribute to because the HSE was the lead agency evaluating all of this. What awareness do the witnesses have of the monitoring of their efficiency metrics in the system in order to understand where they are going in getting patients through the system, the waiting times and the...

Committee on Drugs Use: A Health-Led Approach: Discussion (Resumed) (17 Oct 2024)

Maurice Quinlivan: First, I thank those who submitted their contributions. They were very interesting to read. On the nursing issue, the witnesses said there were 1,945 registered nurses. I assume they do not believe that is enough. I hope this committee comes up with a recommendation and I should say I am not a full member of the committee. I am just substituting for Deputy Gould today. However, I am...

Committee on Drugs Use: A Health-Led Approach: Discussion (Resumed) (17 Oct 2024)

Maurice Quinlivan: They are excluded in that context also. I have a close relative who is on methadone for cancer treatment.

Committee on Drugs Use: A Health-Led Approach: Discussion (Resumed) (17 Oct 2024)

Maurice Quinlivan: Can Mr. McBrien give us some examples? I represent Limerick City and we have a huge crisis in our emergency department. I would hate to think, as the witness has just explained to us, and I do not mean to downplay someone who has an addiction problem, that doctors might be taken away from a crisis intervention to prescribe methadone. Does that happen all the time?

Committee on Drugs Use: A Health-Led Approach: Discussion (Resumed) (17 Oct 2024)

Maurice Quinlivan: To be crystal clear, for us to change that and what the nurse can do we need to change the legislation.

Committee on Drugs Use: A Health-Led Approach: Discussion (Resumed) (17 Oct 2024)

Maurice Quinlivan: I thank Mr. McBrien for that. I agree with Dr. Kelly's issue regarding pay tenure, career progression, workload in the profession and other workers in addiction services and some of the remuneration and perks. It is not necessarily the case for nursing but some of the people working in that sector have not had a pay rise for a number of years, ten or 11 years in some cases. As I said, I am...

Committee on Drugs Use: A Health-Led Approach: Discussion (Resumed) (17 Oct 2024)

Maurice Quinlivan: Will Dr. Kelly briefly explain how he sees independent oversight working? He also referenced that in his opening statement.

Committee on Drugs Use: A Health-Led Approach: Discussion (Resumed) (17 Oct 2024)

Maurice Quinlivan: Professor Comiskey addressed stigma and how we deal with it. What are the easy wins on that front?

Committee on Drugs Use: A Health-Led Approach: Discussion (Resumed) (17 Oct 2024)

Neasa Hourigan: I welcome our witnesses. I want to touch on stigma but before that I will go back to nurse prescribing. A lot of the discussion we are having today reminds me of when I followed the nurse prescribing journey in diabetes. It reminds me of that a lot, in that it is a lifestyle-based treatment and is very much about who you meet when you go into a clinic. At the front line that is often...

Committee on Drugs Use: A Health-Led Approach: Discussion (Resumed) (17 Oct 2024)

Neasa Hourigan: I presume we should have non-elective modules within training for all medical professionals. Would that be specifically on addiction or would it be more useful for it be about what trauma-centred care looks like?

Committee on Drugs Use: A Health-Led Approach: Discussion (Resumed) (17 Oct 2024)

Neasa Hourigan: Would the other witnesses like to come in on addiction versus trauma led?

Committee on Drugs Use: A Health-Led Approach: Discussion (Resumed) (17 Oct 2024)

Neasa Hourigan: The research suggests that when you are on the front line, those attitudes become more prevalent.

Committee on Drugs Use: A Health-Led Approach: Discussion (Resumed) (17 Oct 2024)

Neasa Hourigan: That would take care of all of our new cohort. There are hundreds of thousands of people working in services that are central or tangential to our health service. How do we hit all of them? Do we need to get everybody into a continuing professional development course on addiction and trauma-like care?

Committee on Drugs Use: A Health-Led Approach: Discussion (Resumed) (17 Oct 2024)

Neasa Hourigan: How far along are we on that journey?

Committee on Drugs Use: A Health-Led Approach: Discussion (Resumed) (17 Oct 2024)

Neasa Hourigan: Working in an emergency department is different from working in a laboratory.

Committee on Drugs Use: A Health-Led Approach: Discussion (Resumed) (17 Oct 2024)

Neasa Hourigan: I will return to the question of the inspection of services. I am a member of the Joint Committee on Health, where we talk a lot about the inspection side of things in the context of oversight, performance indicators and outcomes. Who would do that? Perhaps that is not fair. What kind of a body could the witnesses imagine undertaking that piece of work?

Committee on Drugs Use: A Health-Led Approach: Discussion (Resumed) (17 Oct 2024)

Neasa Hourigan: Could Dr. Kelly give me an idea of the breadth and level of that service? Would it include all the third-party and NGO services?